Pfizer's vaccine needing a -80C freezer is making it hard to get it to the most needy people. And shipping containers of 975 doses are making it harder still.
Short thread
Everyone is understandably excited about Pfizer/BioNTech vaccine, w/ 95% efficacy against symptomatic cases (but data not so clear for severe infections:
) a month from now. So time is critical & every day matters.
Which communities are hardest hit by COVID? Usually lower income communities of color. Which communities are less likely to have -80C freezers? Lower income communities of color.
Vaccine can be held at refrigerator temp for 5 d after thawing, so no problem, right? Not so easy. Each box of Pfizer vaccine is 975 doses. What are odds that a given hospital w/out a -80C freezer will have exactly (or at least) 975 people in highest priority category? Not 100%.
What do we do? Do we allocate a box of vaccine to a hospital in a low income area where transmission is raging even if they don't have a -80C freezer or 975 people to vaccinate? Wouldn't that waste precious doses?
You can see the challenges that we are facing now.
No easy solutions. Moderna vaccine has much easier holding conditions and smaller shipments, but lower capacity this year than Pfizer. So, we'll be struggling with this issue for a while.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Why do we exclude groups from vaccine trials (pregnant, lactating women, people w/ anaphylactic reactions) & then allow vaccination of them based on trials? Isn't this recipe for possibly very bad outcomes? Urgent remedy needed.
Thread nytimes.com/2020/12/11/hea…
Pfizer/BioNtech vaccine was just granted EUA from FDA. EUA does not exclude any groups, except children under 16. fda.gov/media/144412/d…
CDC met today & also recommended vaccination w/out clear exclusions for groups excluded (e.g. pregnant women). cnbc.com/2020/12/12/cdc…
But who was excluded from phase 3 trial? Many groups!
Pregnant/breastfeeding women
History of anaphylaxis
Immunocompromised
Those being treated w/ corticosteriods
etc.
What wildlife could be reservoirs for SARS-CoV-2?
New paper suggests North American big brown bats are not. Here's why this is important & why we need more studies like this.
Thread onlinelibrary.wiley.com/doi/10.1111/tb…
We still don't know the natural reservoir for SARS-CoV-2. Some similar viruses were found in horseshoe bats (Rhinolophus spp.), but the difference between those viruses & SARS-CoV-2 is large enough that SARS-CoV-2 may have different reservoir. ncbi.nlm.nih.gov/pmc/articles/P…
Regardless of where SARS-CoV-2 originally came from, many have worried that SARS-CoV-2 might be transmitted from humans into other animals that might be able to sustain the virus & transmit it back to humans.
Who should be vaccinated next?
1st batch Pfizer/BioNTech vaccine is shipping & will go to HCW + nursing homes as it should. But next tier is debated (essential workers? elderly? pre-existing morbidities?).
Model suggests elderly for decreasing deaths but more info needed
Thread
FDA & CDC have given green light for Pfizer/BioNTech vaccine. Supplies are very limited initially & transmission is raging so it's important to choose carefully in who to vaccinate first. How can we determine what is best? Mathematical models!
FDA Pfizer/BioNTech vaccine efficacy results are great, but aren't nearly as great as presented for severe infections.
Everyone has seen fig below on cases in vaccine (blue) & placebo (red) over time.
Thread.
Key aspect of graph: x-axis. It shows days since dose 1 was given. As expected, no difference in total symptomatic cases in vaccine vs placebo for first 7-10d. It takes some time for vaccine to have any effect!
In fact, main reported efficacy of ~95% is for cases starting 7d after 2nd dose. Efficacy for earlier time points are lower: after dose 1, efficacy is 82%.
What fraction of people have been infected w/ SARS-CoV-2?
Are cases in some states (e.g. ND) declining b/c they've reached herd immunity?
Some have suggested that a large fraction of the population in these states have been infected & this is important part of decline.
For example @trvrb recently shared @youyanggu estimate that 30% of ND was infected by Nov 8. There has been another 20K cases (+33% compared to 60K then), so this would suggest ~40% have been infected by now. But how are these calculations being done?
@youyanggu nicely provides details of his calculations here: covid19-projections.com/estimating-tru…
& how they result in a ratio of infections/case on a given day (ratio is assumed to decline over time) given a test positivity.
Will vaccination of health care workers (HCWs) lead to accidental silent spreading of COVID-19?
Big possible downside to vaccine allocation recommendations w/out data on whether vaccines reduce infectiousness.
Thread
The justification for vaccinating HCWs is that they are at high risk of exposure from patients & if infected, removing them from workforce has huge impact on care for patients. So vaccinating them 1st seems like an obvious choice, right? Not w/ available data.
We currently know that 2 vaccines (Pfizer/BioNTech, Moderna) reduce symptomatic infections by ~95%. But we have zero data on whether they reduce infectiousness (& primate studies indicate vaccine didn't eliminate it: nejm.org/doi/pdf/10.105…; biorxiv.org/content/10.110…)